Dr. Robert F. Melendez Joins Ophthalmology Medical Advisory Board
(press release) El Segundo, Calif. — Dr. Robert F. Melendez, CEO/Founder of the Juliet Eye Institute in Albuquerque, New Mexico, is the newest member of the Ocular Science Medical Advisory Board (MAB). A clinical professor at the University of New Mexico Health Sciences Center in Albuquerque, he is also a medical correspondent for ABC-TV affiliates. Participates on boards that establish strategies focused on He is affiliated with Ocular Science 503A Dispensary Pharmacy OSRX.
Having performed over 15,000 cataract and refractive surgeries and providing the first Laser Cataract Surgery (LenSx) and SMILE in Albuquerque, Dr. Melendez founded his own business magazine (Ophthalmology Business Minute) and served as a Lieutenant Colonel in the U.S. Air Force. Before leaving the military, he was an Aviation Surgeon.
“My practice is based on the philosophy that the company behind the product must provide exemplary customer service,” says Dr. Melendez. He used pharmaceuticals and quickly learned that they allowed him to provide individualized care for each patient. Ocular Science and his OSRX team understand people and customers better than anyone in the industry.I
I would like to offer my insights and expertise to the Medical Advisory Board of Ophthalmology, a collection of astute medical leaders who partner to improve the patient experience. “
OSRX is a 503A dispensing pharmacy, customizing OMNI by OSRX ophthalmic medicines. This medication is patient-specific and prescribed for surgical vision correction, myopia and glaucoma management. OSRX combines multiple medicines into one bottle, minimizing the complexity of dosing, providing patients with an easy-to-use and cost-effective solution.
“Dr. Melendez has established himself as a thought leader in the industry and has recently emerged as a key voice in pharmaceuticals,” said Eric Garner, chief commercial officer at Ocular Science. . “Combined with his prowess as a surgeon, Dr. Melendez is a well-qualified and welcomed figure on our Medical Advisory Board, an elite group that has helped us achieve record financial growth year after year. is.”